Whole-exome sequencing in three children with sporadic Blau syndrome, one of them co-presenting with recurrent polyserositis

References

• Lu L , Shen M , Jiang D , et al. Blau syndrome with good Reponses to Tocilizumab: a case report and focused literature review. Semin Arthritis Rheum. 2018;47(5):727–731.
   PubMed Web of Science ®Google Scholar
• Ong LT , Nachbur U , Rowczenio D , et al. A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: phenotype and function. Innate Immun. 2017;23(7):578–583.
   PubMed Web of Science ®Google Scholar
• Zeybek C , Basbozkurt G , Gul D , et al. A new mutation in blau syndrome. Case Rep Rheumatol. 2015;2015:463959
   PubMedGoogle Scholar
• Holland GN , Rosenbaum JT. The challenge of Blau syndrome. Am J Ophthalmol. 2018;187:18–19.
   Web of Science ®Google Scholar
• Li C , Zhang J , Li S , et al. Gene mutations and clinical phenotypes in Chinese children with Blau syndrome. Sci China Life Sci. 2017;60(7):758–762.
   PubMed Web of Science ®Google Scholar
• Jain L , Gupta N , Reddy MM , et al. A novel mutation in helical domain 2 of NOD2 in sporadic Blau syndrome. Ocul Immunol Inflamm. 2018;26(2):292–294.
   PubMed Web of Science ®Google Scholar
• Wouters CH , Maes A , Foley KP , et al. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J. 2014;12:33
   PubMed Web of Science ®Google Scholar
• Imayoshi M , Ogata Y , Yamamoto S. A case of sporadic Blau syndrome with an uncommon clinical course. Case Rep Rheumatol. 2018;2018:6292308
   PubMedGoogle Scholar
• Rose CD. Blau syndrome: a systemic granulomatous disease of cutaneous onset and phenotypic complexity. Pediatr Dermatol. 2017;34(2):216–218.
   PubMed Web of Science ®Google Scholar
• Parkhouse R , Boyle JP , Monie TP. Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators. FEBS Lett. 2014;588(18):3382–3389.
   PubMed Web of Science ®Google Scholar
• Velickovic J , Silan F , Dincsoy Bir F , et al. Blau syndrome with a rare mutation in exon 9 of NOD2 gene. Autoimmunity. 2019;52(7–8):256–263.
   PubMed Web of Science ®Google Scholar
• Yao Q , Li E , Shen B. Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine. Autoimmunity. 2019;52(2):48–56.
   PubMed Web of Science ®Google Scholar
• Caso F , Galozzi P , Costa L , et al. Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease. RMD Open. 2015;1(1):e000097.
   PubMed Web of Science ®Google Scholar
• Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107(5):689–693.
   PubMed Web of Science ®Google Scholar
• Rose CD , Martin TM , Wouters CH. Blau syndrome revisited. Curr Opin Rheumatol. 2011;23(5):411–418.
   PubMed Web of Science ®Google Scholar
• Acosta-Herrera M , Kerick M , González-Serna D , et al. Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases. Ann Rheum Dis. 2019;78(3):311–319.
   PubMed Web of Science ®Google Scholar
• Miceli-Richard C , Lesage S , Rybojad M , et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29(1):19–20.
   PubMed Web of Science ®Google Scholar
• Kanazawa N , Okafuji I , Kambe N , et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood. 2005;105(3):1195–1197.
   PubMed Web of Science ®Google Scholar
• Dhondt V , Hofman S , Dahan K , et al. Leg ulcers: a new symptom of Blau syndrome? Eur J Dermatol. 2008;18(6):635–637.
   PubMed Web of Science ®Google Scholar
• Takeuchi Y , Shigemura T , Kobayashi N , et al. Early diagnosis of early-onset sarcoidosis: a case report with functional analysis and review of the literature. Clin Rheumatol. 2017;36(5):1189–1196.
   PubMed Web of Science ®Google Scholar
• Consortium U. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47(D1):D506–D515.
   PubMed Web of Science ®Google Scholar
• Ogura Y , Bonen DK , Inohara N , et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411(6837):603–606.
   PubMed Web of Science ®Google Scholar
• Shohat M. Familial Mediterranean fever [Internet]. In: Adam MP , Ardinger HH , Pagon RA , et al. , editors. GeneReviews^® . Seattle (WA): University of Washington, Seattle; 1993–2019. [Updated 2016 Dec 15; cited 2019 Nov 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1227/
   Google Scholar
• Bernot A , da Silva C , Petit JL , et al. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet. 1998;7(8):1317–1325.
   PubMed Web of Science ®Google Scholar
• Aksentijevich I , Torosyan Y , Samuels J , et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet. 1999;64(4):949–962.
   PubMed Web of Science ®Google Scholar
• Yildiz M , Adrovic A , Tasdemir E , et al. Evaluation of co-existing diseases in children with familial Mediterranean fever. Rheumatol Int. 2020;40(1):57–64.
   PubMed Web of Science ®Google Scholar
• Feng Y , Zheng P , Zhao H , et al. SLC22A4 and SLC22A5 gene polymorphisms and Crohn's disease in the Chinese Han population. J Dig Dis. 2009;10(3):181–187.
   PubMed Web of Science ®Google Scholar
• McDonald C , Shen M , Johnson EE , et al. Alterations in nucleotide-binding oligomerization domain-2 expression, pathway activation, and cytokine production in Yao syndrome. Autoimmunity. 2018;51(2):53–61.
   PubMed Web of Science ®Google Scholar